Melanie Ivarsson BSc, PhD, MBA

Melanie Ivarsson, PhD is currently Vice President, Head of Clinical Programs at Shire where she has accountability for the delivery of clinical research programs in phase I-IV. Prior to joining Shire, Melanie was at Pfizer for 9 years, most recently as Head of Clinical Operations for the Clinical Research organization. Melanie has a background in early clinical development, with previous roles as Head of Clinical Operations for early development at Pfizer UK, and 8 years at Eil Lilly in the Clinical Pharmacology group. She has a PhD in Neuroscience and a BSc in Physiology from the University of Bristol, UK and completed post-doctoral research at the University of New York, USA and the University of Lund, Sweden. Melanie is currently studying for her Executive MBA at MIT.